Xerostomia Dry Mouth Disease Therapeutics Market: Advanced Saliva Substitutes and Regenerative Research Accelerating Innovation
Rising global prevalence of medication-induced dry mouth, aging populations, autoimmune conditions such as Sjögren's syndrome, and growing head and neck cancer survivorship after radiation therapy are driving steady expansion across the Xerostomia Dry Mouth Disease Therapeutics Market, with industry benchmarks spanning roughly USD 1.93 billion to USD 2.3 billion in 2026 toward USD 3.0...
0 Kommentare 0 Geteilt 2 Ansichten 0 Bewertungen
social art-inpa https://social.art-inpa.com